Pharmaceutical Market Europe (PME)
PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.
From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME’s got it covered.
PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.
AZ speeds first-line lung cancer filing for Tagrisso to EMA
As FLAURA trial results show boosted progression-free survival
Sanofi confirms suspected safety issue with dengue vaccine
As rival Takeda conduct phase II testing for its own dengue vaccine candidate
Merck and Pfizer’s PD-L1 drug Bavencio flunks phase III trial
Fails late-stage stomach cancer study
NICE set to reject wider use of Eisai’s Halaven
Issues draft guidance recommending against second-line use in breast cancer
Adding value to company leadership
Why many find it difficult to achieve
Reading human behaviour to create a medical future
Sanofi’s Dr Anne Beal and Dr Bernard Hamelin on unlocking the doors to patient behaviour
The same key agile principles with a different twist
Securing behavioural change has become a global obsession that s driving a step change in healthcare communications
Is AI changing the future of healthcare?
How technology is playing a big role in healthcare
In the November issue of PME behaviour change looms large, with Sanofi’s global head of patient solutions Dr Anne Beal talking to us about the company’s new behavioural science advisory board
Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app
Editor – Dominic Tyer
Have your say.
Parexel expands global regulatory services team
Robert Iser, Dr Bob Desai and Dr Chang Lee join the biopharma services firm
‘Nothing about us without us’
Why patient engagement is essential throughout the entire product life cycle
J J launches digital skincare challenge
Seeks start-ups focused on tackling areas such as skin health adherence treatment